 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol IDs
|
|
|
| |
A Phase II Trial of Adjuvant Radiation Therapy With Ifosfamide and Cisplatin in Patients With MMT of the Uterus
|
|
|
|
Phase II
|
|
|
|
MMC-03-02-040
NCT00231842
|
|
| |
Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus
|
|
|
|
Phase II
|
|
|
|
GOG-0087M
GOG-0087M, NCT00379145
|
|
| |
VEGF Trap in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
|
|
|
|
Phase II
|
|
|
|
PMH-PHL-051
7502, NCI-7502, NCT00390234
|
|
| |
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
|
|
|
|
Phase II
|
|
|
|
MSKCC-05122
NCT00445965
|
|
| |
Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
|
|
|
|
Phase II
|
|
|
|
CINJ-3330
NCT00161187
|
|
| |
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally
Recurrent Sarcomas
|
|
|
|
Phase II
|
|
|
|
MSKCC-07054
07-054, PFIZER-MSKCC-07054, NCT00474994
|
|
| |
Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus
|
|
|
|
Phase II
|
|
|
|
06-063
NCT00476086
|
|
| |
Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus
|
|
|
|
Phase II
|
|
|
|
ID01-229
NCT00502203
|
|
| |
Irinotecan (Camptosar) in Patients With Advanced Sarcomas
|
|
|
|
Phase II
|
|
|
|
DM03-0002
NCT00509860
|
|
| |
Paclitaxel, Carboplatin, and BSI-201 in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer
|
|
|
|
Phase II
|
|
|
|
GOG-0232C
GOG-0232C, NCT00588744
|
|
